3D Printing for Drug Delivery and its Pharmaceutical Applications – Recent Findings and Challenges
DOI:
https://doi.org/10.37285/ijpsn.2022.15.2.11Abstract
3D Printing technology also known as Additive Manufacturing is a rapid prototyping process that construct solid product with various geometrics by successive layers of material by the use of Computer-Aided Design (CAD). The introduction of 3DP technology in the pharmaceutical industry has opened new horizons in the research and development of printed materials and devices. The main benefit of 3DP lies in the production of small batches of medicines each with tailored dosages, shape, size, and release characteristics. This paper presents the current status of research and development in 3DP technology, background and basic procedure involved in 3DP, main components and types of 3DP, different methods and polymers used, advantages, limitations, and applications of 3D printing technology.
Downloads
Metrics
Keywords:
Drug delivery, 3D Printing technology, Pharmaceutical additive manufacturing, Personalized medicine, Computer-aided design, Polymers, Fused deposition modeling, Stereolithography, Selective laser sintering, Thermal inkjetDownloads
Published
How to Cite
Issue
Section
References
Abaci, A. et al. (2021) “Additive manufacturing of oral tablets: Technologies, materials, and printed tablets,” Pharmaceutics. MDPI pp. 1-27. doi:10.3390/pharmaceutics13020156.
Al-Dulimi, Z. et al. (2021) “3D printing technology as innovative solutions for biomedical applications,” Drug Discovery Today. Elsevier Ltd, pp. 360–383. doi:10.1016/j.drudis.2020.11.013.
Ali, A., Ahmad, U. and Akhtar, J. (2020) “3D Printing in Pharmaceutical Sector: An Overview,” in Pharmaceutical Formulation Design - Recent Practices. IntechOpen. doi:10.5772/intec-hopen.90738.
Araújo, M.R.P. et al. (2019) “The digital pharmacies era: How 3D printing technology using fused deposition modeling can become a reality,” Pharmaceutics. MDPI AG. doi:10.3390/pharmaceutics11030128.
Asmari, M., Sil, B.C. and Patel, B. (2020) “An Undergraduate Study for the Comparison of Dissolution Profiles using 3D Printed PVA and Commercial Paracetamol Tablets,” Materials Highlights, 1(1–2), p. 22. doi:10.2991/mathi.k. 200829.001.
Bakhatwar, M. and Chikkala, S.R. (2019) “Three-dimensional printing in pharmaceutical technology - An overview of innovations,” Innovations in Pharmaceuticals and Pharmacotherapy, pp. 67–71.
Beck, R.C.R. et al. (2017) “3D printed tablets loaded with polymeric nanocapsules: An innovative approach to produce customized drug delivery systems,” International Journal of Pharmaceutics, 528(1–2), pp. 268–279. doi:10.1016/j.ijpharm.2017.05.074.
Beer, N. et al. (2021) “Scenarios for 3D printing of personalized medicines - A case study,” Exploratory Research in Clinical and Social Pharmacy, 4, p. 100073. doi:10.1016/j.rcsop.2021.100073.
Beg, S. et al. (2020) “3D printing for drug delivery and biomedical applications,” Drug Discovery Today, 25(9), pp. 1668–1681. doi:10.1016/j.drudis.2020.07.007.
Bhattacharya, S.A. et al. (2019) “Recent Findings and Development of 3D Printing Technology in Pharmaceutical Formulation Development: An Extensive Review Article in,” International Journal of Drug Development & Research [Preprint]. doi:10.36648/0975-9344.11.4.142.
Borandeh, S. et al. (2021) “Polymeric drug delivery systems by additive manufacturing,” Advanced Drug Delivery Reviews, 173, pp. 349–373. doi:10.1016/j.addr.2021.03.022.
Cailleaux, S. et al. (2021) “Fused Deposition Modeling (FDM), the new asset for the production of tailored medicines,” Journal of Controlled Release, 330, pp. 821–841. doi:10.1016/j.jconrel.2020.10.056.
Chandekar, A. et al. (2019) “3D Printing Technology: A New Milestone in the Development of Pharmaceuticals,” Current Pharmaceutical Design, 25(9), pp. 937–945. doi:10.2174/1381612825666190507115504.
Cheng, Y. et al. (2020) “3D printing of extended-release tablets of theophylline using hydroxypropyl methylcellulose (HPMC) hydrogels,” International Journal of Pharmaceutics, 591, p. 119983. doi:10.1016/j.ijpharm.2020.119983.
Chi, H.Y. et al. (2020) “Fabrication of polylactic acid/paclitaxel nanofibers by electrospinning for cancer therapeutics,” BMC Chemistry, 14(1). doi:10.1186/s13065-020-00711-4.
Deshmane, S. et al. (2021) “Stereolithography 3D printing technology in pharmaceuticals: a review,” Drug Development and Industrial Pharmacy, pp. 1–11. doi:10.1080/03639045.2021.1994990.
Gao, G. et al. (2021) “3D Printing of Pharmaceutical Application: Drug Screening and Drug Delivery,” Pharmaceutics, 13(9), p. 1373. doi:10.3390/pharmaceutics13091373.
Gaurav et al. (2021) “Recent update of 3D printing technology in pharmaceutical formulation development,” Journal of Biomaterials Science, Polymer Edition, 32(17), pp. 2306–2330. doi:10.1080/09205063.2021.1967702.
GV, S. et al. (2017) “3D printing of PCL/Fluorouracil tablets by selective laser sintering: Properties of implantable drug delivery for cartilage cancer treatment,” Rheumatology and Orthopedic Medicine, 2(3). doi:10.15761/ROM.1000121.
Haris, M.S. et al. (2020) “3D-printed Drugs: A Fabrication of Pharmaceuticals towards Personalized Medicine,” Indian Journal of Pharmaceutical Education and Research, 54(3s), pp. s411–s422. doi:10.5530/ijper.54.3s.139.
Ho, C.M.B. et al. (2017) “3D Printed Polycaprolactone Carbon Nanotube Composite Scaffolds for Cardiac Tissue Engineering,” Macromolecular Bioscience, 17(4), p. 1600250. doi:10.1002/mabi.201600250.
Homaee Borujeni, S. et al. (2020) “Three-dimensional (3D) printed tablets using ethyl cellulose and hydroxypropyl cellulose to achieve zero-order sustained release profile,” Cellulose, 27(3), pp. 1573–1589. doi:10.1007/s10570-019-02881-4.
Horst, D.J. (2018) “3D Printing of Pharmaceutical Drug Delivery Systems,” Archives of Organic and Inorganic Chemical Sciences, 1(2). doi:10.32474/AOICS.2018.01.000109.
Jacob, S. et al. (2020) “3D Printing Technologies: Recent Development and Emerging Applications in Various Drug Delivery Systems,” AAPS PharmSciTech, 21(6), p. 220. doi:10.1208/s12249-020-01771-4.
Jamróz, W. et al. (2018) “3D Printing in Pharmaceutical and Medical Applications – Recent Achievements and Challenges,” Pharmaceutical Research, 35(9), p. 176. doi:10.1007/s11095-018-2454-x.
Jose, P.A., and GV, P.C. (2018) “3d Printing of Pharmaceuticals – A Potential Technology In Developing Personalized Medicine,” Asian Journal of Pharmaceutical Research and Development, 6(3), pp. 46–54. doi:10.22270/ajprd.v6i3.375.
Khaled, S.A. et al. (2015) “3D printing of tablets containing multiple drugs with defined release profiles,” International Journal of Pharmaceutics, 494(2). doi:10.1016/j.ijpharm.2015.07.067.
Konta, A., García-Piña, M., and Serrano, D. (2017) “Personalised 3D Printed Medicines: Which Techniques and Polymers Are More Successful?,” Bioengineering, 4(4), p. 79. doi:10.3390/bioengineering4040079.
Lamichhane, S. et al. (2019) “Complex formulations, simple techniques: Can 3D printing technology be the Midas touch in the pharmaceutical industry?” Asian Journal of Pharmaceutical Sciences, 14(5), pp. 465–479. doi:10.1016/j.ajps.2018.11.008.
Lepowsky, E. and Tasoglu, S. (2018) “3D printing for drug manufacturing: A perspective on the future of pharmaceuticals,” International Journal of Bioprinting, 4(1). doi:10.18063/IJB.v4i1.119.
Loureiro, J.A. and Pereira, M.C. (2020) “PLGA based drug carrier and pharmaceutical applications: The most recent advances,” Pharmaceutics. MDPI AG, pp. 1–5. doi:10.3390/pharmaceutics12090903.
Macedo, J. et al. (2020) “Processability of poly(vinyl alcohol) Based Filaments With Paracetamol Prepared by Hot-Melt Extrusion for Additive Manufacturing,” Journal of Pharmaceutical Sciences, 109(12), pp. 3636–3644. doi:10.1016/j.xphs.2020.09.016.
Maulvi, F.A. (no date) “Application of 3D Printing Technology in the Development of Novel Drug Delivery Systems.”
Melocchi, A. et al. (2020) “A Graphical Review on the Escalation of Fused Deposition Modeling (FDM) 3D Printing in the Pharmaceutical Field,” Journal of Pharmaceutical Sciences. Elsevier B.V., pp. 2943–2957. doi:10.1016/j.xphs.2020.07.011.
Mohapatra, S. et al. (2022) “Approaches of 3D printing in current drug delivery,” Sensors International, 3, p. 100146. doi:10.1016/j.sintl.2021.100146.
Mule, S.T. et al. (2020) “Recent Trends, Opportunities and Challenges in 3D Printing Technology for Personalized Medicine,” Journal of Drug Delivery and Therapeutics, 10(4), pp. 242–252. doi:10.22270/jddt.v10i4.4143.
Nandi, S. (2020) “3d Printing of Pharmaceuticals – Leading Trend In Pharmaceutical Industry And Future Perspectives,” Asian Journal of Pharmaceutical and Clinical Research, pp. 10–16. doi:10.22159/ajpcr.2020.v13i12.39584.
Ngo, T.D. et al. (2018) “Additive manufacturing (3D printing): A review of materials, methods, applications, and challenges,” Composites Part B: Engineering, 143, pp. 172–196. doi:10.1016/j.compositesb.2018.02.012.
Oyewumi, M. (2015) “3D Printing Technology in Pharmaceutical Drug Delivery: Prospects and Challenges,” Journal of Biomolecular Research & Therapeutics, 04(04). doi:10.4172/2167-7956.1000e141.
Pandey, M. et al. (2020) “3D printing for oral drug delivery: a new tool to customize drug delivery,” Drug Delivery and Translational Research, 10(4), pp. 986–1001. doi:10.1007/s13346-020-00737-0.
Parhi, R. (2021) “A review of three-dimensional printing for pharmaceutical applications: Quality control, risk assessment and future perspectives,” Journal of Drug Delivery Science and Technology, 64, p. 102571. doi:10.1016/j.jddst.2021.102571.
Parulski, C. et al. (2021) “Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now?,” Advanced Drug Delivery Reviews. Elsevier B.V. doi:10.1016/j.addr.2021.05.020.
Petersmann, S. et al. (2019) “Impact Optimization of 3D‐Printed Poly(methyl methacrylate) for Cranial Implants,” Macromolecular Materials and Engineering, 304(11), p. 1900263. doi:10.1002/mame.201900263.
dos Santos, J. et al. (2021) “Eudragit®: A versatile family of polymers for hot melt extrusion and 3D printing processes in pharmaceutics,” Pharmaceutics. MDPI. doi:10.3390/pharmaceutics13091424.
Serris, I. et al. (2020) “Development of 3D-Printed Layered PLGA Films for Drug Delivery and Evaluation of Drug Release Behaviors,” AAPS PharmSciTech, 21(7), p. 256. doi:10.1208/s12249-020-01790-1.
Singh, S. et al. (2021) “Formulation Design and Evaluation of 3D Printed Tablet of Cinnarizine by Fused Deposition Modeling Technique,” International Journal of Creative Research Thoughts (IJCRT), 9, pp. 5880–5897.
Solanki, N.G. et al. (2018) “Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility, and Printability,” Journal of Pharmaceutical Sciences, 107(1), pp. 390–401. doi:10.1016/j.xphs.2017.10.021.
Tagami, T. et al. (2017) “3D Printing Factors Important for the Fabrication of Polyvinylalcohol Filament-Based Tablets,” Biological & Pharmaceutical Bulletin, 40(3), pp. 357–364. doi:10.1248/bpb.b16-00878.
Tagami, T. et al. (2019) “Drug Incorporation into Polymer Filament Using Simple Soaking Method for Tablet Preparation Using Fused Deposition Modeling,” Biological and Pharmaceutical Bulletin, 42(10), pp. 1753–1760. doi:10.1248/bpb.b19-00482.
Thakur, N. and Murthy, H. (2021) “An overview on 3D Printed Medicine,” Material Science Research India, 18(1), pp. 07–13. doi:10.13005/msri/180102.
Ursan, I.D., Chiu, L. and Pierce, A. (2013) “Three-dimensional drug printing: A structured review,” Journal of the American Pharmacists Association, 53(2), pp. 136–144. doi:10.1331/JAPhA.2013.12217.
Vaz, V.M. and Kumar, L. (2021) “3D Printing as a Promising Tool in Personalized Medicine,” AAPS PharmSciTech, 22(1). doi:10.1208/s12249-020-01905-8.
Vinchurkar, K. (2018) “3D Printing:-A Review,” Jour. Harmon. Res. Pharm, 7(4). doi:10.30876/JOHR.7.4.2018.XX-XX.
Wei, C. et al. (2020) “Development of 3D Printed Tablets by Fused Deposition Modeling Using Polyvinyl Alcohol as Polymeric Matrix for Rapid Drug Release,” Journal of Pharmaceutical Sciences, 109(4), pp. 1558–1572. doi:10.1016/j.xphs.2020.01.015.
